FORSØG I CENTER FOR DERMATOLOGI

Oversigt over åbne forsøg i Center for Dermatologi 2017
  • A phase Ib, blinded, randomized, multicenter, multiple-ascending-dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of UTTR 1147A, administered by subcutaneous injection in patients with non-healing neuropathic diabetic foot ulcers.
  • Multi-center, Double-blind, Randomised, Placebo-controlled, Phase IIa Study to Investigate Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacogenomics of Multiple Intravenous Doses of BI 655130 in Patients With Palmoplantar Pustulosis (PPP).
Aktivitetsoversigt for afdelinger i Center for Dermatologi Q1-Q4 2016

Igangværende forsøg (fyldt) og initierede forsøg (skraveret)

NEXT kontaktperson for dermatologi

Karina Markersen

Mobil:+45 24 42 58 55

E-mail: kma@nextpartnership.dk